ANGO vs GS · rev $292.5M vs P/E 20, $324.25B cap
AngioDynamics Inc (ANGO) versus Goldman Sachs Group Inc (GS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
GS does not have a complete income-statement cache yet.
ANGO currently screens at market cap $378.5M. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Not investment advice. Open the ANGO and GS stock pages for the full models.
Not investment advice.